Influence of a 100-km Ultra-Marathon on Hepatitis B Carrier Runners

Abstract

This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.

Key words

clinical sports medicine - hepatitis B virus carrier ­runner - liver function impairment - inflammatory response - ultra-marathon

• References

• 1 Asplund CA, O’Connor FG, Noakes TD. Exercise-associated collapse: an evidence-based review and primer for clinicians. Br J Sports Med 2011; 45: 1157-1162
• 2 Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M. Evidence for an exercise induced increase of TNF-α and IL-6 in marathon runners. Scand J Med Sci Sports 2011; [Epub ahead of print]
• 3 Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002; 36: 1408-1415
• 4 Clarkson PM. Exertional rhabdomyolysis and acute renal failure in marathon runners. Sports Med 2007; 37: 361-363
• 5 Fallon KE, Sivyer G, Sivyer K, Dare A. The biochemistry of runners in a 1600 km ultramarathon. Br J Sports Med. 1999 33. 264-269
• 6 Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc Immunol Rev 2006; 12: 6-33
• 7 Harriss DJ, Atkinson G. Update – ethical standards in sport and exercise science research. Int J Sports Med 2011; 32: 819-821
• 8 Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49: S156-S165
• 9 Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005; 2: 50-57
• 10 Kao WF, Shyu CL, Yang XW, Hsu TF, Chen JJ, Kao WC, Polun-Chang, Huang YJ, Kuo FC, Huang CI, Lee CH. Athletic performance and serial weight changes during 12- and 24-hour ultra-marathons. Clin J Sport Med 2008; 18: 155-158
• 11 Kipps C, Sharma S, Pedoe DT. The incidence of exercise-associated hyponatraemia in the London marathon. Br J Sports Med 2011; 45: 14-19
• 12 Knechtle B, Gnädinger M, Knechtle P, Imoberdorf R, Kohler G, Ballmer P, Rosemann T, Senn O. Prevalence of exercise-associated hyponatremia in male ultraendurance athletes. Clin J Sport Med 2011; 21: 226-232
• 13 Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol 2002; 118: 856-863
• 14 Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Significant variation of traditional markers of liver injury after a half-marathon run. Eur J Intern Med 2011; 22: e36-e38
• 15 Liu CJ, Chen PJ, Lai MY, Kao JH, Chang CF, Wu HL, Shau WY, Chen DS. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 2003; 124: 80-90
• 16 Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539
• 17 McGarvey J, Thompson J, Hanna C, Noakes TD, Stewart J, Speedy D. Sensitivity and specificity of clinical signs for assessment of dehydration in endurance athletes. Br J Sports Med 2010; 44: 716-719
• 18 Meyering C, Howard T. Hypercoagulability in athletes. Curr Sports Med Rep 2004; 3: 77-83
• 19 Nagel D, Seiler D, Franz H, Jung K. Ultra-long-distance running and the liver. Int J Sports Med 1990; 11: 441-445
• 20 Nieman DC. Marathon training and immune function. Sports Med 2007; 37: 412-415
• 21 Nieman DC, Dumke CI, Henson DA, McAnulty SR, McAnulty LS, Lind RH, Morrow JD. Immune and oxidative changes during and following the Western States Endurance Run. Int J Sports Med 2003; 24: 541-547
• 22 Roberts WO. Exertional heat stroke in the marathon. Sports Med 2007; 37: 440-443
• 23 Siegel AJ, Januzzi J, Sluss P, Lee-Lewandrowski E, Wood M, Shirey T, Lewandrowski KB. Cardiac biomarkers, electrolytes, and other analytes in collapsed marathon runners: implications for the evaluation of runners following competition. Am J Clin Pathol 2008; 129: 948-951
• 24 Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 2004; 38: 292-294
• 25 Tunstall Pedoe DS. Marathon cardiac deaths: the London experience. Sports Med 2007; 37: 448-450
• 26 Waśkiewicz Z, Kłapcińska B, Sadowska-Krępa E, Czuba M, Kempa K, Kimsa E, Gerasimuk D. Acute metabolic responses to a 24-h ultra-marathon race in male amateur runners. Eur J Appl Physiol 2012; 112: 1679-1688
• 27 Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006 43. S173-S181